1. Home
  2. LAB

LAB

Standard BioTools Inc.

Logo Standard BioTools Inc.

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-15-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Founded: 1999 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 1.1B IPO Year: 2011
Target Price: $3.63 AVG Volume (30 days): 2.0M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.94 EPS Growth: N/A
52 Week Low/High: $1.46 - $3.16 Next Earning Date: 05-07-2024
Revenue: $106,340,000 Revenue Growth: 8.57%
Revenue Growth (this year): 89.98% Revenue Growth (next year): 15.48%

Share on Social Networks: